These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29226173)

  • 1. Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.
    Reepalu A; Balcha TT; Sturegård E; Medstrand P; Björkman P
    Open Forum Infect Dis; 2017; 4(4):ofx219. PubMed ID: 29226173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis.
    Reepalu A; Balcha TT; Skogmar S; Jemal ZH; Sturegård E; Medstrand P; Björkman P
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19612. PubMed ID: 25394116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosis.
    Reepalu A; Balcha TT; Skogmar S; Jemal ZH; Sturegård E; Medstrand P; Björkman P
    Open Forum Infect Dis; 2014 Mar; 1(1):ofu039. PubMed ID: 25734107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV.
    Thorman J; Björkman P; Marrone G; Tolera Balcha T; Tesfaye F; Abdissa T; Naniche D; Medstrand P; Reepalu A
    Microbiol Spectr; 2021 Dec; 9(3):e0181021. PubMed ID: 34908450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.
    Reepalu A; Balcha TT; Skogmar S; Güner N; Sturegård E; Björkman P
    PLoS One; 2016; 11(6):e0156602. PubMed ID: 27272622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
    Bassett IV; Chetty S; Wang B; Mazibuko M; Giddy J; Lu Z; Walensky RP; Freedberg KA; Losina E
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):25-30. PubMed ID: 22027877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
    Siika AM; Yiannoutsos CT; Wools-Kaloustian KK; Musick BS; Mwangi AW; Diero LO; Kimaiyo SN; Tierney WM; Carter JE
    PLoS One; 2013; 8(1):e53022. PubMed ID: 23301015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.
    Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
    PLoS One; 2014; 9(4):e94271. PubMed ID: 24714066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
    Skogmar S; Schön T; Balcha TT; Jemal ZH; Tibesso G; Björk J; Björkman P
    PLoS One; 2013; 8(12):e83270. PubMed ID: 24358268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
    Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
    BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
    Schöni-Affolter F; Keiser O; Mwango A; Stringer J; Ledergerber B; Mulenga L; Bucher HC; Westfall AO; Calmy A; Boulle A; Chintu N; Egger M; Chi BH; ;
    PLoS One; 2011; 6(12):e27919. PubMed ID: 22205933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.